ArticleVaccine2021

Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.

Miguel García-Grimshaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.